Could a simple exercise programme boost asthma remission?

NCT ID NCT07735494

Recruiting now Disease control Sponsor: University of Leeds Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether adding a 12-week physical activity promotion programme to standard tezepelumab treatment helps more adults with severe asthma achieve clinical remission. Participants are randomly assigned to receive either standard care alone or standard care plus the programme, which includes coaching, goal setting, and a smartphone app. The study will compare remission rates and other outcomes after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a 12-week structured physical activity promotion programme
What this could lead to: If it works, this could point toward a way to improve remission rates and quality of life for people with severe asthma by combining exercise support with biologic therapy.
What could go wrong: This is a relatively small, early-stage trial. The physical activity programme may not be enough to boost remission, and participants may find it hard to stick with the programme.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEVERE ASTHMA

Contacts and locations

Locations

Leeds Teaching Hospitals NHS Trust
RECRUITING

Leeds, LS9 7TF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.